Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Drug News & Perspectives|March 5, 2009
Bruton's tyrosine kinase as a drug discovery targetZhengying PanEuropean Journal of Medicinal Chemistry|June 1, 2026
Discovery of pyrazole-based selective covalent ITK inhibitors with In vivo activityZhiyang Ruan, Zhengying PanChemical Communications (Cambridge, England)|October 28, 2014
A general approach for the development of fluorogenic probes suitable for no-wash imaging of kinases in live cellsQing Zhang, Hui Liu, Zhengying PanOrganic Letters|October 31, 2014
Synthesis of highly substituted imidazolidine-2,4-dione (hydantoin) through Tf2O-mediated dual activation of Boc-protected dipeptidyl compoundsHui Liu, Zhimin Yang, Zhengying PanEuropean Journal of Medicinal Chemistry|December 21, 2023
Development of visible-light-activatable photocaged PROTACsWeizhi Weng, Gang Xue, Zhengying PanEuropean Journal of Medicinal Chemistry|November 4, 2025
Development of a series of novel potent and selective irreversible covalent FGFR4 inhibitors with a mix-and-match strategyJiajun Huang, Zhenpeng Zhong, Zhengying PanEuropean Journal of Medicinal Chemistry|December 13, 2019
Design, synthesis and structure-activity relationship of indolylindazoles as potent and selective covalent inhibitors of interleukin-2 inducible T-cell kinase (ITK)Xueying Wang, Gang Xue, Zhengying PanJournal of the American Chemical Society|October 10, 2024
Potent Inhibition and Rapid Photoactivation of Endogenous Bruton's Tyrosine Kinase Activity in Native Cells via Opto-Covalent ModulatorsWeizhi Weng, Ping Zhang, Zhengying PanJournal of Medicinal Chemistry|March 23, 2023
Discovery of Potent and Highly Selective Interleukin-2-Inducible T-Cell Kinase Degraders with <i>In Vivo</i> ActivityDanli Zhou, Yingying Zuo, Zhengying PanRSC Medicinal Chemistry|September 12, 2022
Introduction to the themed collection on Covalent Drug DiscoveryKeriann M Backus, Zhengying Pan, Lyn H JonesPageof 4